Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome : Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
Our scientific premise is that in AE-PCOS women, the androgen-dominant hormonal milieu causes BP increases via sympathetic activation, vasoconstriction and renal sympathetic nervous system activation. Moreover, this androgen-dominant milieu increases BP via activation of the renin-angiotensin system..
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ClinicalTrials.gov - (2024) vom: 02. Feb. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
610 |
---|
Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: March 31, 2020, Last downloaded: ClinicalTrials.gov processed this data on February 07, 2024, Last updated: February 07, 2024 |
---|
Study ID: |
NCT04327934 |
---|---|
Veröffentlichungen zur Studie: |
|
fisyears: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
CTG003345491 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CTG003345491 | ||
003 | DE-627 | ||
005 | 20240207010559.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210408s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG003345491 | ||
035 | |a (UBBS_Klinische_Studien)NCT04327934 | ||
035 | |a (UBBS_Klinische_Studien)2000020950 | ||
035 | |a (UBBS_Klinische_Studien)R01HL135089-01A1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome |b Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: March 31, 2020, Last downloaded: ClinicalTrials.gov processed this data on February 07, 2024, Last updated: February 07, 2024 | ||
520 | |a Our scientific premise is that in AE-PCOS women, the androgen-dominant hormonal milieu causes BP increases via sympathetic activation, vasoconstriction and renal sympathetic nervous system activation. Moreover, this androgen-dominant milieu increases BP via activation of the renin-angiotensin system. | ||
650 | 2 | |a Polycystic Ovary Syndrome | |
650 | 2 | |a Hypertension | |
650 | 2 | |a Syndrome | |
650 | 4 | |a Study Type: Interventional | |
650 | 4 | |a Recruitment Status: Terminated | |
650 | 4 | |a Phase: Early Phase 1 | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2024) vom: 02. Feb. |
773 | 1 | 8 | |g year:2024 |g day:02 |g month:02 |
856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT04327934 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
951 | |a AR | ||
952 | |j 2024 |b 02 |c 02 |